| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1090776828 |
| P356 | DOI | 10.1038/SDATA.2017.91 |
| P932 | PMC publication ID | 5516542 |
| P698 | PubMed publication ID | 28722704 |
| P50 | author | Richard D. Smith | Q7325058 |
| Wei-Jun Qian | Q58327364 | ||
| Athena A Schepmoes | Q89297502 | ||
| Tujin Shi | Q89716172 | ||
| Karin Rodland | Q90008917 | ||
| Yuqian Gao | Q90331736 | ||
| Marina A. Gritsenko | Q111457989 | ||
| Thomas L Fillmore | Q117216489 | ||
| Ehwang Song | Q117216527 | ||
| P2093 | author name string | Tao Liu | |
| Song Nie | |||
| Chaochao Wu | |||
| P2860 | cites work | Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels | Q24652836 |
| Status of large-scale analysis of post-translational modifications by mass spectrometry | Q26829144 | ||
| Advances in targeted proteomics and applications to biomedical research | Q28066912 | ||
| The human plasma proteome: history, character, and diagnostic prospects | Q28218148 | ||
| PCNA: a silent housekeeper or a potential therapeutic target? | Q28236494 | ||
| Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome | Q28468274 | ||
| TANDEM: matching proteins with tandem mass spectra | Q29615238 | ||
| Mass-spectrometry-based draft of the human proteome | Q29617249 | ||
| A draft map of the human proteome | Q29617250 | ||
| Proliferating cell nuclear antigen (PCNA): a dancer with many partners | Q29620131 | ||
| Skyline: an open source document editor for creating and analyzing targeted proteomics experiments | Q30080030 | ||
| Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards | Q30759842 | ||
| Targeted proteomics driven verification of biomarker candidates associated with breast cancer aggressiveness. | Q51131303 | ||
| Multiplexed panel of precisely quantified salivary proteins for biomarker assessment. | Q51564069 | ||
| Immunohistochemical study of glutathione-related enzymes and proliferative antigens in lung cancer. Relation to cisplatin sensitivity. | Q54244534 | ||
| Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy | Q72691179 | ||
| Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses | Q73280999 | ||
| Antibody-free PRISM-SRM for multiplexed protein quantification: is this the new competition for immunoassays in bioanalysis? | Q86085647 | ||
| The CPTAC Data Portal: A Resource for Cancer Proteomics Research | Q30931875 | ||
| High-throughput generation of selected reaction-monitoring assays for proteins and proteomes | Q33517451 | ||
| Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry | Q33639352 | ||
| Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma | Q33794491 | ||
| Space-time wiring specificity supports direction selectivity in the retina | Q33820561 | ||
| CPTAC Assay Portal: a repository of targeted proteomic assays | Q33960135 | ||
| Towards identification of true cancer biomarkers | Q34168702 | ||
| The evolving role of mass spectrometry in cancer biomarker discovery | Q34215422 | ||
| Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions | Q34279143 | ||
| EVA: Exome Variation Analyzer, an efficient and versatile tool for filtering strategies in medical genomics | Q34457238 | ||
| Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics | Q34487045 | ||
| Targeted quantitation of proteins by mass spectrometry. | Q34630866 | ||
| Abundance-based classifier for the prediction of mass spectrometric peptide detectability upon enrichment (PPA). | Q35148591 | ||
| Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer? | Q36080431 | ||
| Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests | Q36136098 | ||
| Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum | Q36280125 | ||
| PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows | Q36638849 | ||
| Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays | Q36794987 | ||
| Selected reaction monitoring for quantitative proteomics: a tutorial | Q36973024 | ||
| Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium | Q37238264 | ||
| Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays | Q37244496 | ||
| A list of candidate cancer biomarkers for targeted proteomics | Q37277962 | ||
| Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach | Q37623655 | ||
| The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification | Q37653063 | ||
| CONSeQuence: prediction of reference peptides for absolute quantitative proteomics using consensus machine learning approaches | Q39451492 | ||
| Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. | Q39636313 | ||
| High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics. | Q40636072 | ||
| Enzymatic digestion of proteins in solution | Q42169396 | ||
| Interlaboratory agreement of insulin-like growth factor 1 concentrations measured by mass spectrometry | Q44680101 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 170091 | |
| P577 | publication date | 2017-07-19 | |
| P1433 | published in | Scientific Data | Q27725928 |
| P1476 | title | Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer | |
| P478 | volume | 4 |
| Q64096309 | Clinical potential of mass spectrometry-based proteogenomics |
| Q96134614 | Recent advances in mass spectrometry based clinical proteomics: applications to cancer research |
| Q52335444 | Targeted mass spectrometry enables robust quantification of FANCD2 mono-ubiquitination in response to DNA damage. |
Search more.